Hong Kong

2 Vaccines Approved for Use in Hong Kong

RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
84 trials in 27 countries
Approval Source: reuters.com
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
37 trials in 9 countries
Approval Source: reuters.com

5 in Clinical Trials in Hong Kong

RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
84 trials in 27 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
64 trials in 31 countries
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
37 trials in 9 countries
DNA

The University of Hong Kong

SARS-CoV-2 DNA Vaccine

Replicating Viral Vector

The University of Hong Kong

DelNS1-nCoV-RBD LAIV